Lead Product(s): Asenapine Maleate
Therapeutic Area: Psychiatry/Psychology Product Name: Asenapine TTS
Highest Development Status: Preclinical Product Type: Small molecule
Partner/Sponsor/Collaborator: Livzon Pharmaceutical Group Inc.
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Licensing Agreement July 06, 2020
LTS grants to LIVZON and its Affiliates an exclusive royalty-bearing, sublicensable right and license to jointly develop with LTS the Asenapine TTS and commercialize the Asenapine TTS for the treatment of schizophrenia in China (including Hong Kong and Macau).